ProShares Ultra Health Care (RXL)
Upgrades & Downgrades
Latest RXL news
Biotech Innovations Remain At Forefront
16 April 2021
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r...
Healthcare: A Wide Choice Of Large And Well-Established Companies
19 February 2021
The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets...